rheumatology
Medicines

Methotrexate the culprit in anti-TNF skin cancer link

New Australian research spanning three decades provides “conclusive” evidence linking methotrexate with an increased risk of non-melanoma skin cancer. The role of methotrexate and anti-TNFS used to treat RA in elevated skin cancer risk have been the subject of much debate, but the large study published in Rheumatology should put the speculation to rest, said ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic